Transdiagnostic Dimensional Profiling of Neurodevelopmental Disorders - NCT07544199
Summary
A new observational study (NCT07544199) was registered April 22, 2026, investigating cognitive function profiles in children ages 3-11 with neurodevelopmental disorders. The study employs the CRAB (Computerized Reading-related Assessment Battery) digital platform developed by SUPSI and the Université de Genève to assess both domain-general cognitive functions (attention, working memory, executive control) and domain-specific functions (phonological awareness, rapid naming, vocabulary, reading). Participating families receive a coded email link to access the platform, with game-like tasks administered remotely under the supervision of IRCCS Medea in Italy.
“CRAB is a digital platform specifically developed by SUPSI and the Université de Genève to integrate, within a single testing environment, the assessment of the main domain-general and domain-specific cognitive functions underlying neurodevelopmental disorders.”
About this source
GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 734 changes logged to date.
What changed
A new observational study (NCT07544199) titled 'Transdiagnostic Dimensional Profiling of Neurodevelopmental Disorders' was registered on ClinicalTrials.gov. The study aims to provide a fine-grained, multidimensional mapping of cognitive profiles in preschool and school-age children (3-11 years) using the CRAB digital assessment platform developed by SUPSI and the Université de Genève. The study evaluates both domain-general cognitive functions and domain-specific functions underlying neurodevelopmental disorders, with participants recruited through IRCCS Medea in Italy.
Healthcare providers and clinical researchers working in pediatric neurodevelopmental assessment should be aware of this study as it represents a transdiagnostic approach to cognitive profiling. The use of a standardized digital platform (CRAB) for both domain-general and domain-specific cognitive assessment may inform future best practices in neurodevelopmental evaluation.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Transdiagnostic Dimensional Profiling of Neurodevelopmental Disorders
Observational NCT07544199 Kind: OBSERVATIONAL Apr 22, 2026
Abstract
In recent years, the growing awareness of the multifactorial nature of neurodevelopmental disorders has stimulated interest in transdiagnostic approaches aimed at investigating underlying etiological mechanisms beyond traditional diagnostic categories. In this context, the present study seeks to provide a transdiagnostic profiling of both domain-general cognitive functions (attention, working memory, executive control) and domain-specific functions (phonological awareness, rapid naming, vocabulary, reading) underlying the main neurodevelopmental disorders in a large sample of preschool and school-age children (3-11 years), through the use of CRAB (Computerized Reading-related Assessment Battery). CRAB is a digital platform specifically developed by SUPSI and the Université de Genève to integrate, within a single testing environment, the assessment of the main domain-general and domain-specific cognitive functions underlying neurodevelopmental disorders. In particular, participating families will receive an email containing a link to access the CRAB platform, which will not include their personal data but rather a code provided by the staff of IRCCS Medea. A screen will open displaying several game-like tasks designed to measure both domain-general and domain-specific cognitive functions, which must be completed by the participating subject. The main objective is to obtain a fine-grained and multidimensional mapping of cognitive profiles prior to the standard diagnostic pro...
Conditions: Neurodevelopmental Disorder (Diagnosis)
Interventions: Neuropsychological assessment
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH/NLM.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.